These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer. Hoff PM; Pazdur R; Benner SE; Canetta R Anticancer Drugs; 1998 Jul; 9(6):479-90. PubMed ID: 9877235 [TBL] [Abstract][Full Text] [Related]
16. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC). Vestermark LW; Jacobsen A; Qvortrup C; Hansen F; Bisgaard C; Baatrup G; Rasmussen P; Pfeiffer P Acta Oncol; 2008; 47(3):428-33. PubMed ID: 18348002 [TBL] [Abstract][Full Text] [Related]
17. Current and future directions in adjuvant combined-modality therapy of rectal cancer. Minsky BD Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):61-8. PubMed ID: 9348572 [TBL] [Abstract][Full Text] [Related]
18. High-dose radiotherapy and concurrent UFT plus l-leucovorin in locally advanced rectal cancer: a phase I trial. Pfeiffer P Acta Oncol; 2005; 44(3):224-9. PubMed ID: 16076693 [TBL] [Abstract][Full Text] [Related]
19. UFT and oral calcium folinate as first-line chemotherapy for metastatic gastric cancer. Ravaud A; Borner M; Schellens JH; Geoffrois L; Schöffski P; Wanders J; Hanauske AR Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):61-3. PubMed ID: 10442364 [TBL] [Abstract][Full Text] [Related]
20. UFT in the treatment of colorectal and breast cancer. Sun W; Haller D Oncology (Williston Park); 2001 Jan; 15(1 Suppl 2):49-56. PubMed ID: 11219978 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]